Maofang Lin

595 total citations
48 papers, 437 citations indexed

About

Maofang Lin is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Maofang Lin has authored 48 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Maofang Lin's work include Hematopoietic Stem Cell Transplantation (8 papers), Retinoids in leukemia and cellular processes (6 papers) and Acute Myeloid Leukemia Research (6 papers). Maofang Lin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Retinoids in leukemia and cellular processes (6 papers) and Acute Myeloid Leukemia Research (6 papers). Maofang Lin collaborates with scholars based in China, Taiwan and United States. Maofang Lin's co-authors include Xiujin Ye, Jimin Shi, Jingsong He, Yi Luo, Wanzhuo Xie, Zhen Cai, He Huang, Yamin Tan, Haowen Xiao and Xiaohong Yu and has published in prestigious journals such as Blood, PLoS ONE and Journal of The Electrochemical Society.

In The Last Decade

Maofang Lin

43 papers receiving 428 citations

Peers

Maofang Lin
Scott Melvin United States
Maofang Lin
Citations per year, relative to Maofang Lin Maofang Lin (= 1×) peers Scott Melvin

Countries citing papers authored by Maofang Lin

Since Specialization
Citations

This map shows the geographic impact of Maofang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maofang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maofang Lin more than expected).

Fields of papers citing papers by Maofang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maofang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maofang Lin. The network helps show where Maofang Lin may publish in the future.

Co-authorship network of co-authors of Maofang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Maofang Lin. A scholar is included among the top collaborators of Maofang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maofang Lin. Maofang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mingming, Huarui Fu, Xiaoyu Lai, et al.. (2016). Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia. PLoS ONE. 11(10). e0163599–e0163599. 6 indexed citations
2.
Luo, Yi, Haowen Xiao, Xiaoyu Lai, et al.. (2014). T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood. 124(17). 2735–2743. 139 indexed citations
3.
Lin, Maofang, Jian Hou, Xiao‐Jun Huang, et al.. (2014). Improved Response Rates with Bortezomib in Relapsed or Refractory Multiple Myeloma: An Observational Study in Chinese Patients. Advances in Therapy. 31(10). 1082–1094. 11 indexed citations
4.
Xie, Wanzhuo, Fan Xu, De Zhou, et al.. (2013). Significance of clinical factors as prognostic indicators for patients with peripheral T-cell non-Hodgkin lymphoma: A retrospective analysis of 252 cases. Molecular and Clinical Oncology. 1(5). 911–917. 5 indexed citations
5.
He, Jingsong, et al.. (2013). Inhibition of p38 MAPK Phosphorylation Is Critical for Bestatin to Enhance ATRA-Induced Cell Differentiation in Acute Promyelocytic Leukemia NB4 Cells. American Journal of Therapeutics. 23(3). e680–e689. 7 indexed citations
6.
Xie, Wanzhuo, De Zhou, Jimin Shi, et al.. (2013). Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy. Experimental and Therapeutic Medicine. 6(1). 109–114. 15 indexed citations
7.
Xie, Wanzhuo, Fan Xu, De Zhou, et al.. (2012). Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma. Annals of Hematology. 92(4). 481–486. 13 indexed citations
8.
He, Jingsong, Li Yang, Guoqing Wei, et al.. (2012). A Retrospective Analysis of Cytogenetic and Clinical Characteristics in Patients With Multiple Myeloma. The American Journal of the Medical Sciences. 345(2). 88–93. 5 indexed citations
9.
Cao, Weijie, Haowen Xiao, Xiaoyu Lai, et al.. (2011). Genetic Variations in the Mycophenolate Mofetil Target Enzyme Are Associated with Acute GVHD Risk after Related and Unrelated Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(2). 273–279. 11 indexed citations
10.
Xiao, Haowen, Weijie Cao, Xiaoyu Lai, et al.. (2010). Immunosuppressive Cytokine Gene Polymorphisms and Outcome after Related and Unrelated Hematopoietic Cell Transplantation in a Chinese Population. Biology of Blood and Marrow Transplantation. 17(4). 542–549. 19 indexed citations
11.
Zheng, Weiyan, Yi Luo, Yamin Tan, et al.. (2010). Evaluation the Risk Factor of Transplantation-Associated Thrombotic Microangiopathy.. Blood. 116(21). 4527–4527.
13.
Zheng, Weiyan, Guoqing Wei, Xiujin Ye, et al.. (2009). Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience. Leukemia Research. 33(12). 1615–1618. 12 indexed citations
14.
Qiu, Lei, Jingsong He, Xiujin Ye, et al.. (2009). Invasive pulmonary fungal infection accompanied by severe hemoptysis in patients with hematologic diseases: a report of nine cases. International Journal of Hematology. 90(1). 108–112. 1 indexed citations
15.
Zhao, Yanmin, Lizhen Liu, Yingjia Wang, et al.. (2009). Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population. International Journal of Hematology. 89(4). 445–451. 13 indexed citations
16.
Zhu, Yuanyuan, Jimin Shi, Jie Sun, et al.. (2004). [Expression of Pin1 in malignant hematopoietic cells and its relation with cell cycle].. PubMed. 33(6). 500–3, 514. 2 indexed citations
17.
Lan, Jianping, Yi Luo, Yuanyuan Zhu, et al.. (2004). [Isolation of Tara protein and its gene cloning].. PubMed. 33(6). 486–90. 3 indexed citations
18.
Lan, Jianping, Yuanyuan Zhu, Jingyuan Li, et al.. (2004). [Localization of human telomere repeat binding factor 1 in telomerase-positive and-negative cells and its expression during cell cycle].. PubMed. 33(6). 475–80, 495. 3 indexed citations
19.
Wang, Lijun, et al.. (2003). [The clinical significance of angiogenesis in the bone marrow of acute leukemia patients].. PubMed. 42(7). 486–9. 3 indexed citations
20.
Hwang, G. J. & Maofang Lin. (1995). Estimation of the Onset of Longitudinal Vortices in a Laminar Boundary Layer Heated From Below. Journal of Heat Transfer. 117(4). 835–842. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026